International Healthcare M&A advisory firm MedWorld Advisors announces the formation of the MedTech Laser Group via the acquisition of shares of A.R.C Laser GmbH, a German company based in Nuremberg, and of G.N.S. neoLaser Ltd. an Israeli company based in Caesarea (close to Tel Aviv, Israel), by Afinum 9, advised by Afinum Management GmbH, based in Munich, Germany. 

A.R.C. Laser, a private, family-owned enterprise established in 1996, has a long-standing history as a pioneering platform in medical laser technology development. The company offers an extensive range of innovative laser technologies focused on ophthalmic treatments, particularly for glaucoma and cataract procedures. Leveraging its strong R&D capabilities, A.R.C. Laser has successfully diversified its product portfolio to include surgical applications e.g. in Laryngology, Otology, Rhinology, as well as Veterinary medicine. 

neoLaser, also privately owned, was founded in 2012 and stands out as a fast-growing specialist in laser systems and fibers for Endovenous Laser Ablation and applications in Proctology. neoLaser's advanced laser solutions have positioned it as a leader in its respective fields, driving significant advancements in patient care and treatment outcomes.

Afinum, an independent investment firm focusing on small- and medium-sized companies, has been active since 2000. Focusing on four tech enabled verticals: Healthcare, Industrial Technology, Software & TMT and Consumer & Internet, Afinum partners with successful entrepreneurs to develop companies to their full potential based on a trustful partnership approach. Autonomy and preservation of corporate culture and identity are of unique importance. This transaction marks the tenth platform investment of the Afinum 9 fund and the third thematic investment in the MedTech sector. 

In this partnership, the founders of A.R.C Laser and neoLaser will jointly invest in the formation of this integrated medical laser technology company. As part of the transaction, Afinum acquires a significant majority stake while the founders re-invest in the newly formed entity.

The global market for ophthalmologic and surgical lasers is poised for substantial growth, driven by various secular trends such as aging population, increasing prevalence of relevant diseases, and technological advancements in laser treatments driving adoption across medical disciplines. This market opportunity underscores the strategic rationale behind the formation of the MedTech Laser Group, aimed at capitalizing on these growth drivers to deliver innovative medical solutions. 

Under the umbrella of the MedTech Laser Group, A.R.C. Laser and neoLaser will be able to jointly capitalize on this market opportunity. The partnership is designed to harness synergies for further topline growth. The companies will continue to operate as independent entities while leveraging their combined strengths to collaborate on research and development, sales and marketing, as well as regulatory matters. The joint growth strategy will emphasize international expansion, an enhanced go to market approach and further driving organizational development. Furthermore, the group will broaden its technology and product portfolio organically and potentially through strategic add-on acquisitions.

MedWorld Advisors represented the sellers in this transaction as their exclusive advisor, and facilitated and managed the unique transaction, bringing A.R.C. Laser and neoLaser, two privately owned companies headquartered and operating in different countries. These companies sought a partner to assist in international market expansion, who would not upset the integrity of the cultures both companies have carefully fostered. The sellers’ role as key strategic investors in the new integrated group displays their strong belief in the partnership and its capabilities.